Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

View all journals
Search
Log in

nature
search

Search

Advanced search

Filter By:

Journal Check one or more journals to show results from those journals only.

Oncogene (7)
Modern Pathology (2)
Scientific Reports (2)
Laboratory Investigation (1)
Nature Biotechnology (1)

Choose more journals

Article type Check one or more article types to show results from those article types only.

Research (14)

Subject Check one or more subjects to show results from those subjects only.

Biological techniques
Cancer
Cell biology
Chemical biology
Chemistry
Drug discovery
Molecular biology
Molecular medicine
Pathogenesis
Risk factors

Date Choose a date option to show results from those dates only.

Today
Last 7 days
Last 30 days
Last 12 months
Last 2 years
Last 5 years

Custom date range

Clear all filters

Sort by:

Relevance

Date published (new to old)

Date published (old to new)

Showing 1–14 of 14 results

Advanced filters: Author: Göran Landberg Clear advanced filters

Downregulation of the potential suppressor gene IGFBP-rP1 in human breast cancer is associated with inactivation of the retinoblastoma protein, cyclin E overexpression and increased proliferation in estrogen receptor negative tumors

Göran Landberg
Hanna Östlund
Arun Seth
Research27 Jun 2001
Oncogene

Volume: 20, P: 3497-3505
Ovarian tumor cells gain competitive advantage by actively reducing the cellular fitness of microenvironment cells

Reduced fitness of the tumor microenvironment is mediated by a long non-coding RNA expressed in tumors.

Esha Madan
António M. Palma
Rajan Gogna
Research09 Dec 2024
Nature Biotechnology

Volume: 43, P: 1833-1847
Breast cancer patient-derived scaffolds enhance the understanding of PD-L1 regulation and T cell cytotoxicity

Patient-derived scaffolds illuminate the impact of unique tumor microenvironments on T cell interactions with cancer cells, underscoring the importance of incorporating human-based and varying cancer niches in breast cancer modeling.

Elena Garre
Sara Rhost
Göran Landberg
ResearchOpen Access16 Apr 2025
Communications Biology

Volume: 8, P: 1-12
Cyclin E dependent kinase activity in human breast cancer in relation to cyclin E, p27 and p21 expression and retinoblastoma protein phosphorylation

Martin Lodén
Niels Hilmer Nielsen
Göran Landberg
Research27 Apr 1999
Oncogene

Volume: 18, P: 2557-2566
The cyclin D1 high and cyclin E high subgroups of breast cancer: separate pathways in tumorogenesis based on pattern of genetic aberrations and inactivation of the pRb node

Martin Lodén
Maria Stighall
Göran Landberg
Research05 Jul 2002
Oncogene

Volume: 21, P: 4680-4690
Deregulation of cyclin E and D1 in breast cancer is associated with inactivation of the retinoblastoma protein

Niels H Nielsen
Stefan O Emdin
Göran Landberg
Research23 Jan 1997
Oncogene

Volume: 14, P: 295-304
An inverse association between plasma benzoxazinoid metabolites and PSA after rye intake in men with prostate cancer revealed with a new method

Elise Nordin
Stine K. Steffensen
Rikard Landberg
ResearchOpen Access28 Mar 2022
Scientific Reports

Volume: 12, P: 1-14
Retinoblastoma protein function and p16^INK4a expression in actinic keratosis, squamous cell carcinoma in situ and invasive squamous cell carcinoma of the skin and links between p16^INK4a expression and infiltrative behavior

Kristina Nilsson
Sofie Svensson
Göran Landberg
Research16 Jul 2004
Modern Pathology

Volume: 17, P: 1464-1474
Regulation of the cyclin A1 protein is associated with its differential subcellular localization in hematopoietic and leukemic cells

Jenny Ekberg
Göran Landberg
Jenny Liao Persson
Research18 Oct 2004
Oncogene

Volume: 23, P: 9082-9089
ERK1/2 inhibition increases antiestrogen treatment efficacy by interfering with hypoxia-induced downregulation of ERα: a combination therapy potentially targeting hypoxic and dormant tumor cells

Åsa Kronblad
Ingrid Hedenfalk
Göran Landberg
Research27 Jun 2005
Oncogene

Volume: 24, P: 6835-6841
Patient-derived scaffolds as a drug-testing platform for endocrine therapies in breast cancer

Anna Gustafsson
Elena Garre
Göran Landberg
ResearchOpen Access25 Jun 2021
Scientific Reports

Volume: 11, P: 1-12
ERK phosphorylation is linked to VEGFR2 expression and Ets-2 phosphorylation in breast cancer and is associated with tamoxifen treatment resistance and small tumours with good prognosis

Sofie Svensson
Karin Jirström
Göran Landberg
Research04 Apr 2005
Oncogene

Volume: 24, P: 4370-4379
Nuclear expression of the RNA-binding protein RBM3 is associated with an improved clinical outcome in breast cancer

Annika Jögi
Donal J Brennan
Karin Jirström
Research04 Sept 2009
Modern Pathology

Volume: 22, P: 1564-1574
Identification of inhibitors regulating cell proliferation and FUS-DDIT3 expression in myxoid liposarcoma using combined DNA, mRNA, and protein analyses

David Svec
Soheila Dolatabadi
Anders Ståhlberg
ResearchOpen Access27 Mar 2018
Laboratory Investigation

Volume: 98, P: 957-967

Search

Search articles by subject, keyword or author

Show results from

Advanced search

Quick links

Explore articles by subject
Find a job
Guide to authors
Editorial policies

Nature.com

nature.com sitemap

About Nature Portfolio

About us
Press releases
Press office
Contact us

Discover content

Journals A-Z
Articles by subject
protocols.io
Nature Index

Publishing policies

Nature portfolio policies
Open access

Author & Researcher services

Reprints & permissions
Research data
Language editing
Scientific editing
Nature Masterclasses
Research Solutions

Libraries & institutions

Librarian service & tools
Librarian portal
Open research
Recommend to library

Advertising & partnerships

Advertising
Partnerships & Services
Media kits
Branded content

Professional development

Nature Awards
Nature Careers
Nature Conferences

Regional websites

Nature Africa
Nature China
Nature India
Nature Japan
Nature Middle East

Privacy Policy
Use of cookies
Legal notice
Accessibility statement
Terms & Conditions
Your US state privacy rights

Search

Downregulation of the potential suppressor gene IGFBP-rP1 in human breast cancer is associated with inactivation of the retinoblastoma protein, cyclin E overexpression and increased proliferation in estrogen receptor negative tumors

Ovarian tumor cells gain competitive advantage by actively reducing the cellular fitness of microenvironment cells

Breast cancer patient-derived scaffolds enhance the understanding of PD-L1 regulation and T cell cytotoxicity

Cyclin E dependent kinase activity in human breast cancer in relation to cyclin E, p27 and p21 expression and retinoblastoma protein phosphorylation

The cyclin D1 high and cyclin E high subgroups of breast cancer: separate pathways in tumorogenesis based on pattern of genetic aberrations and inactivation of the pRb node

Deregulation of cyclin E and D1 in breast cancer is associated with inactivation of the retinoblastoma protein

An inverse association between plasma benzoxazinoid metabolites and PSA after rye intake in men with prostate cancer revealed with a new method

Retinoblastoma protein function and p16^INK4a expression in actinic keratosis, squamous cell carcinoma in situ and invasive squamous cell carcinoma of the skin and links between p16^INK4a expression and infiltrative behavior

Regulation of the cyclin A1 protein is associated with its differential subcellular localization in hematopoietic and leukemic cells

ERK1/2 inhibition increases antiestrogen treatment efficacy by interfering with hypoxia-induced downregulation of ERα: a combination therapy potentially targeting hypoxic and dormant tumor cells

Patient-derived scaffolds as a drug-testing platform for endocrine therapies in breast cancer

ERK phosphorylation is linked to VEGFR2 expression and Ets-2 phosphorylation in breast cancer and is associated with tamoxifen treatment resistance and small tumours with good prognosis

Nuclear expression of the RNA-binding protein RBM3 is associated with an improved clinical outcome in breast cancer

Identification of inhibitors regulating cell proliferation and FUS-DDIT3 expression in myxoid liposarcoma using combined DNA, mRNA, and protein analyses

Search

Quick links